ShapeTX

1 follower

Shape Therapeutics is a biotechnology company developing next-generation RNA-targeted therapies to treat the world’s most challenging diseases.

Employees

51-200

Links


Org chart

Adrian W Briggs
VP, Head of Platform Technologies
Ken Prentice
VP, Head of Process and Product Development
Collin H.
Director, Cell & Vector Engineering
Marsha Mason
Associate Director, Program and Portfolio Management
Stephanie Blij
Vice President, Head Of Legal
Ron Hause
VP, Head of Analytics and Informatics
Kevin Stein
Director Of Computational Biology